Literature DB >> 6459350

Plasma GABA in affective illness. A preliminary investigation.

F Petty, M A Schlesser.   

Abstract

Plasma levels of gamma-aminobutyric acid (GABA) were determined in 34 clinically symptomatic patients with diagnosis of affective disorder and in 20 normal controls. Lowest levels were found in patients with familial pure depressive disease and in depression spectrum disease, while levels of patients with sporadic depressive disease, though significantly lower than control, were not as low. Plasma GABA levels in secondary depression and in bipolar depression were similar to control. Bipolar manic patients had plasma GABA levels that were significantly higher than control values.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459350     DOI: 10.1016/0165-0327(81)90003-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  18 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

2.  Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide.

Authors:  He Zhu; Beata Karolewicz; Emily Nail; Craig A Stockmeier; Katalin Szebeni; Gregory A Ordway
Journal:  Brain Res       Date:  2006-11-21       Impact factor: 3.252

3.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

4.  Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis.

Authors:  Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Mood Anxiety Disord       Date:  2014-03-07

5.  Changes in central GABAergic function following acute and repeated stress.

Authors:  M E Otero Losada
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

6.  Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression.

Authors:  Bruno Romeo; Walid Choucha; Philippe Fossati; Jean-Yves Rotge
Journal:  J Psychiatry Neurosci       Date:  2017-10-02       Impact factor: 6.186

7.  Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice.

Authors:  Saiful Alom Siddique; Thangavel Tamilselvan; Manikkannan Vishnupriya; Elumalai Balamurugan
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

8.  Reduced expression of GABA transporter GAT3 in helpless rats, an animal model of depression.

Authors:  M Zink; B Vollmayr; P J Gebicke-Haerter; F A Henn
Journal:  Neurochem Res       Date:  2009-03-15       Impact factor: 3.996

9.  Vigabatrin and depression.

Authors:  H A Ring; R Crellin; S Kirker; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

10.  Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes.

Authors:  J A Cross; R W Horton
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.